Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- PMID: 19847166
- PMCID: PMC2783335
- DOI: 10.1038/nature08460
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Abstract
The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. A complementary strategy for targeting KRAS is to identify gene products that, when inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkappaB kinase TBK1 was selectively essential in cells that contain mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving c-Rel and BCL-XL (also known as BCL2L1) that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations indicate that TBK1 and NF-kappaB signalling are essential in KRAS mutant tumours, and establish a general approach for the rational identification of co-dependent pathways in cancer.
Figures
Comment in
-
Cancer: A tumour gene's fatal flaws.Nature. 2009 Nov 5;462(7269):44-5. doi: 10.1038/462044a. Nature. 2009. PMID: 19890318 No abstract available.
Similar articles
-
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.Nature. 2016 Oct 6;538(7623):114-117. doi: 10.1038/nature19771. Epub 2016 Sep 28. Nature. 2016. PMID: 27680702 Free PMC article.
-
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.Cell. 2009 May 29;137(5):821-34. doi: 10.1016/j.cell.2009.03.017. Cell. 2009. PMID: 19490892
-
Evaluating TBK1 as a therapeutic target in cancers with activated IRF3.Mol Cancer Res. 2014 Jul;12(7):1055-66. doi: 10.1158/1541-7786.MCR-13-0642. Epub 2014 Apr 21. Mol Cancer Res. 2014. PMID: 24752990
-
KRAS: A Promising Therapeutic Target for Cancer Treatment.Curr Top Med Chem. 2019;19(23):2081-2097. doi: 10.2174/1568026619666190905164144. Curr Top Med Chem. 2019. PMID: 31486755 Review.
-
The Application of the RNA Interference Technologies for KRAS: Current Status, Future Perspective and Associated Challenges.Curr Top Med Chem. 2019;19(23):2143-2157. doi: 10.2174/1568026619666190828162217. Curr Top Med Chem. 2019. PMID: 31456522 Review.
Cited by
-
Identification of immune patterns in idiopathic pulmonary fibrosis patients driven by PLA2G7-positive macrophages using an integrated machine learning survival framework.Sci Rep. 2024 Sep 27;14(1):22369. doi: 10.1038/s41598-024-73625-z. Sci Rep. 2024. PMID: 39333367 Free PMC article.
-
Proteogenomic characterization of skull-base chordoma.Nat Commun. 2024 Sep 27;15(1):8338. doi: 10.1038/s41467-024-52285-7. Nat Commun. 2024. PMID: 39333076 Free PMC article.
-
Unraveling the immune landscape of lung adenocarcinoma: insights for tailoring therapeutic approaches.Discov Oncol. 2024 Sep 27;15(1):470. doi: 10.1007/s12672-024-01396-0. Discov Oncol. 2024. PMID: 39331252 Free PMC article.
-
Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer.Cells. 2024 Sep 10;13(18):1518. doi: 10.3390/cells13181518. Cells. 2024. PMID: 39329702 Free PMC article.
-
Integrated machine learning and bioinformatic analysis of mitochondrial-related signature in chronic rhinosinusitis with nasal polyps.World Allergy Organ J. 2024 Sep 19;17(10):100964. doi: 10.1016/j.waojou.2024.100964. eCollection 2024 Oct. World Allergy Organ J. 2024. PMID: 39328210 Free PMC article.
References
-
- Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH. Integrating genetic approaches into the discovery of anticancer drugs. Science. 1997;278:1064–1068. - PubMed
-
- Kaelin WG., Jr The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer. 2005;5:689–698. - PubMed
-
- Moffat J, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006;124:1283–1298. - PubMed
-
- Malo N, Hanley JA, Cerquozzi S, Pelletier J, Nadon R. Statistical practice in high-throughput screening data analysis. Nat Biotechnol. 2006;24:167–175. - PubMed
-
- Gould J, Getz G, Monti S, Reich M, Mesirov JP. Comparative gene marker selection suite. Bioinformatics. 2006;22:1924–1925. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous